LLC Insight Holdings Group Sells Shares of Hinge Health, Inc.
LLC Insight Holdings Group sold shares of Hinge Health on June 24, 2026.
Key Points
- LLC Insight Holdings Group sold 533,228 shares of Hinge Health, Inc. (HNGE) on June 24, 2026.
- Hinge Health traded near $70.38 on Thursday, with a market cap of $5.33 billion and a forward P/E of 20.59.
- Analysts from Wells Fargo and others maintained a 'buy' rating, setting a target price up to $90.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
LLC Insight Holdings Group sold shares of Hinge Health, Inc. (NYSE: HNGE) on June 24, 2026. The transaction involved 533,228 shares. On Thursday, Hinge Health's stock traded near $70.38.
Other Institutional Activity in Hinge Health
Among other institutional investors, Deer Management Co. LLC opened a new position with 2,633,707 shares valued at about $101.56 million. Meanwhile, Bit Capital GmbH reduced its holdings by 1,006,304 shares, leaving it with 2,309,797 shares worth approximately $89.07 million, marking a 30.3% decrease. RTW Investments, LP increased its position by 1,576,500 shares, ending with 1,930,000 shares valued at $74.42 million, reflecting a 446% increase.
Hinge Health, Inc. Stock Down 19.2%
Shares of NYSE:HNGE traded near $70.38 on Thursday. Hinge Health has a market cap of $5.33 billion and a forward P/E ratio of 20.59. The stock's 52-week range is between $30.08 and $71.43. It has a 50-day moving average of $52.90 and a 200-day moving average of $47.85. The company's current ratio is 1.303, with a quick ratio of 1.039 and a debt-to-equity ratio of 2.237.
$HNGE stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Hinge Health reported revenue of $646.34 million, showing a growth of 47.2%. However, the company is not yet profitable, with a net margin of -78.95% and a return on equity of -136%. The next earnings report is expected on August 4, 2026.
Insider Buying and Selling at Hinge Health, Inc.
On June 24, 2026, LLC Insight Holdings Group sold 533,228 shares at an average price of $71.29 under a planned sale. The same entity made additional transactions on June 23, 2026, selling 112,477 shares at a price of $70.21 in a planned transaction.
Analysts Set New Price Targets
On June 24, 2026, Wells Fargo maintained its 'buy' rating with a price target of $90.0. Other firms like Raymond James and Canaccord Genuity also maintained 'buy' ratings with targets of $80.0 and $76.0, respectively. The consensus among 15 analysts is a 'buy' recommendation with a mean target price of $79.73.
About Hinge Health, Inc.
Hinge Health, Inc., based in San Francisco, California, focuses on delivering scalable musculoskeletal care through technology. The company uses AI-powered motion tracking and proprietary devices to offer personalized care for conditions like chronic pain and post-surgical rehabilitation. Founded in 2012, it primarily serves self-insured employers and is led by CEO Daniel A. Perez.
Bottom Line
LLC Insight Holdings Group's recent sale of Hinge Health shares is part of regular insider activity. Investors keep an eye on such transactions for potential signals about the company's direction. Hinge Health continues to draw analyst interest with strong 'buy' ratings, despite its current lack of profitability.
Get Hinge Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $HNGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.